Brief: Irlab Q1 Operating Loss Widens To SEK 19.1 Mln
May 7 (Reuters) - IRLAB Therapeutics AB IRLABa.ST :
* Q1 OPERATING LOSS SEK 19.1 MILLION VERSUS LOSS SEK 17.6
MILLION
YEAR AGO
Source text for Eikon: ID:nWkr5q4y7F
Further company coverage: IRLABa.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))